GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (OSTO:CRAD B) » Definitions » EV-to-FCF

C-Rad AB (OSTO:CRAD B) EV-to-FCF : 21.40 (As of May. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is C-Rad AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, C-Rad AB's Enterprise Value is kr1,326.4 Mil. C-Rad AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was kr62.0 Mil. Therefore, C-Rad AB's EV-to-FCF for today is 21.40.

The historical rank and industry rank for C-Rad AB's EV-to-FCF or its related term are showing as below:

OSTO:CRAD B' s EV-to-FCF Range Over the Past 10 Years
Min: -294.24   Med: -12.07   Max: 863.6
Current: 20.45

During the past 13 years, the highest EV-to-FCF of C-Rad AB was 863.60. The lowest was -294.24. And the median was -12.07.

OSTO:CRAD B's EV-to-FCF is ranked better than
60.72% of 359 companies
in the Medical Devices & Instruments industry
Industry Median: 27.9 vs OSTO:CRAD B: 20.45

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-28), C-Rad AB's stock price is kr43.70. C-Rad AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr1.420. Therefore, C-Rad AB's PE Ratio for today is 30.77.


C-Rad AB EV-to-FCF Historical Data

The historical data trend for C-Rad AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB EV-to-FCF Chart

C-Rad AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 271.16 130.47 142.60 -762.86 78.63

C-Rad AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 363.83 -66.04 64.00 78.63 20.97

Competitive Comparison of C-Rad AB's EV-to-FCF

For the Medical Devices subindustry, C-Rad AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Rad AB's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where C-Rad AB's EV-to-FCF falls into.



C-Rad AB EV-to-FCF Calculation

C-Rad AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1326.448/61.983
=21.40

C-Rad AB's current Enterprise Value is kr1,326.4 Mil.
C-Rad AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr62.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-Rad AB  (OSTO:CRAD B) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

C-Rad AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=43.70/1.420
=30.77

C-Rad AB's share price for today is kr43.70.
C-Rad AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.420.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


C-Rad AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of C-Rad AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Rad AB (OSTO:CRAD B) Business Description

Traded in Other Exchanges
Address
Sjukhusvägen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. The operating segments of the group are the Positioning segment which includes development and sales of products in the field of patient positioning during radiotherapy, including catalyst, sentinel, and HIT lasers; and the Imaging segment which includes the development of imaging devices and detectors for cancer treatments and dosimetry. It generates maximum revenue from the Positioning segment. The firm sells its products in Sweden and internationally.

C-Rad AB (OSTO:CRAD B) Headlines

No Headlines